The FDA on Friday approved a new biologic as add-on maintenance treatment for inadequately controlled chronic rhinosinusitis with nasal polyps, according to Amgen and AstraZeneca. DENVER — By ...
The FDA on Friday approved a new biologic as add-on maintenance treatment for inadequately controlled chronic rhinosinusitis with nasal polyps, according to Amgen and AstraZeneca. NASHVILLE — Measles ...
Tension between Indiana University and its student newspaper flared this week with the elimination of the outlet’s print editions and the firing of a faculty adviser, who refused an order to keep news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback